Suresh Jadhav (biotechnology executive)
http://dbpedia.org/resource/Suresh_Jadhav_(biotechnology_executive) an entity of type: Thing
Suresh Jadhav (1948/1949 – 7 December 2021) was an Indian biotechnology executive and a key member of the Indian vaccine manufacturing industry. At the Serum Institute of India (SII) he led the development and introduction of the Meningococcal A conjugate vaccine to Sub-Saharan Africa and the production of the COVID-19 vaccine at SII, including the ones marketed as Covishield. Jadhav was a member of the board of the GAVI vaccine alliance, and a member of the Indian government's expert committee on vaccines and other biologicals and a member of the Indian Pharmacopoeia Commission.
rdf:langString
rdf:langString
Suresh Jadhav (biotechnology executive)
rdf:langString
Suresh Jadhav
rdf:langString
Suresh Jadhav
rdf:langString
Pune, Maharashtra, India
xsd:date
2021-12-07
xsd:integer
69469093
xsd:integer
1108774339
rdf:langString
Jadhav in a 2013 video for Doctors Without Borders
xsd:date
2021-12-07
rdf:langString
Biotechnology executive
rdf:langString
Suresh Jadhav (1948/1949 – 7 December 2021) was an Indian biotechnology executive and a key member of the Indian vaccine manufacturing industry. At the Serum Institute of India (SII) he led the development and introduction of the Meningococcal A conjugate vaccine to Sub-Saharan Africa and the production of the COVID-19 vaccine at SII, including the ones marketed as Covishield. Jadhav was a member of the board of the GAVI vaccine alliance, and a member of the Indian government's expert committee on vaccines and other biologicals and a member of the Indian Pharmacopoeia Commission.
xsd:nonNegativeInteger
12077
xsd:gYear
2021